Clinicopathological correlation analysis showed that, except for gender (Fig. 2H), the expression level of DNAJC3 was significantly correlated with age (Fig. 2C), methylguanine-DNA methyltransferase promoter methylation status (Fig. 2D), isocitrate dehydrogenase (IDH) mutation status (Fig. 2E), WHO grade (Fig. 2F), and transcriptome subtype (Fig. 2G) of glioma patients. The gene discussed is DNAJC3; the disease is central nervous system cancer.